Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III - The OVAR-IMRT-02 Study

BACKGROUND: The prognosis for patients with advanced FIGO stage III epithelial ovarian cancer remains poor despite the aggressive standard treatment, consisting of maximal cytoreductive surgery and platinum-based chemotherapy. The median time to recurrence is less than 2 years, with a 5-years surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Rochet, Nathalie, Kieser, Meinhard, Sterzing, Florian, Krause, Sonja, Lindel, Katja, Harms, Wolfgang, Eichbaum, Michael H, Schneeweiss, Andreas, Sohn, Christof, Debus, Juergen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045983/
https://www.ncbi.nlm.nih.gov/pubmed/21276234
http://dx.doi.org/10.1186/1471-2407-11-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045983/
https://www.ncbi.nlm.nih.gov/pubmed/21276234
http://dx.doi.org/10.1186/1471-2407-11-41

Ejemplares similares